Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Real-time augmented reality for delineation of surgical margins during neurosurgery using autofluorescence lifetime contrast.

Alfonso-Garcia A, Bec J, Sridharan Weaver S, Hartl B, Unger J, Bobinski M, Lechpammer M, Girgis F, Boggan J, Marcu L.

J Biophotonics. 2020 Jan;13(1):e201900108. doi: 10.1002/jbio.201900108. Epub 2019 Aug 9.

PMID:
31304655
2.

The Relationship Between Austrian Tax Auditors and Self-Employed Taxpayers: Evidence From a Qualitative Study.

Gangl K, Hartl B, Hofmann E, Kirchler E.

Front Psychol. 2019 May 13;10:1034. doi: 10.3389/fpsyg.2019.01034. eCollection 2019.

3.

Extinction and the U.S. Endangered Species Act.

Greenwald N, Suckling KF, Hartl B, A Mehrhoff L.

PeerJ. 2019 Apr 22;7:e6803. doi: 10.7717/peerj.6803. eCollection 2019.

4.

Label-free fluorescence lifetime spectroscopy detects radiation-induced necrotic changes in live brain in real-time.

Hartl BA, Ma HSW, Sridharan S, Hansen KS, Kent MS, Gorin F, Fragoso RC, Marcu L.

Biomed Opt Express. 2018 Jul 5;9(8):3559-3580. doi: 10.1364/BOE.9.003559. eCollection 2018 Aug 1.

5.

A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients.

Hartl B, Zeller I, Manhart A, Selitsch B, Lass-Flörl C, Willinger B.

Mycopathologia. 2018 Jun;183(3):513-519. doi: 10.1007/s11046-017-0238-1. Epub 2018 Jan 22.

6.

Defending the scientific integrity of conservation-policy processes.

Carroll C, Hartl B, Goldman GT, Rohlf DJ, Treves A, Kerr JT, Ritchie EG, Kingsford RT, Gibbs KE, Maron M, Watson JEM.

Conserv Biol. 2017 Oct;31(5):967-975. doi: 10.1111/cobi.12958. Epub 2017 Jul 25.

PMID:
28741747
7.

Isolation of eudesmanes from Pluchea odorata and evaluation of their effects on cancer cell growth and tumor invasiveness in vitro.

Blaschke M, Zehl M, Hartl B, Strauß C, Winkler J, Urban E, Krupitza G, Kopp B.

Phytochemistry. 2017 Sep;141:37-47. doi: 10.1016/j.phytochem.2017.05.009. Epub 2017 May 26.

PMID:
28554035
8.

The effect of radiation dose on the onset and progression of radiation-induced brain necrosis in the rat model.

Hartl BA, Ma HSW, Hansen KS, Perks J, Kent MS, Fragoso RC, Marcu L.

Int J Radiat Biol. 2017 Jul;93(7):676-682. doi: 10.1080/09553002.2017.1297902. Epub 2017 Mar 17.

9.

Authorities' Coercive and Legitimate Power: The Impact on Cognitions Underlying Cooperation.

Hofmann E, Hartl B, Gangl K, Hartner-Tiefenthaler M, Kirchler E.

Front Psychol. 2017 Jan 18;8:5. doi: 10.3389/fpsyg.2017.00005. eCollection 2017.

10.

Activating Photodynamic Therapy in vitro with Cerenkov Radiation Generated from Yttrium-90.

Hartl BA, Hirschberg H, Marcu L, Cherry SR.

J Environ Pathol Toxicol Oncol. 2016;35(2):185-92. doi: 10.1615/JEnvironPatholToxicolOncol.2016016903.

11.

Hybrid Quantum Systems with Collectively Coupled Spin States: Suppression of Decoherence through Spectral Hole Burning.

Krimer DO, Hartl B, Rotter S.

Phys Rev Lett. 2015 Jul 17;115(3):033601. Epub 2015 Jul 14.

PMID:
26230793
12.

Combined fiber probe for fluorescence lifetime and Raman spectroscopy.

Dochow S, Ma D, Latka I, Bocklitz T, Hartl B, Bec J, Fatakdawala H, Marple E, Urmey K, Wachsmann-Hogiu S, Schmitt M, Marcu L, Popp J.

Anal Bioanal Chem. 2015 Nov;407(27):8291-301. doi: 10.1007/s00216-015-8800-5. Epub 2015 Jun 21.

13.

Does the sole description of a tax authority affect tax evasion?--the impact of described coercive and legitimate power.

Hartl B, Hofmann E, Gangl K, Hartner-Tiefenthaler M, Kirchler E.

PLoS One. 2015 Apr 29;10(4):e0123355. doi: 10.1371/journal.pone.0123355. eCollection 2015.

14.

Characterizing low fluence thresholds for in vitro photodynamic therapy.

Hartl BA, Hirschberg H, Marcu L, Cherry SR.

Biomed Opt Express. 2015 Feb 10;6(3):770-9. doi: 10.1364/BOE.6.000770. eCollection 2015 Mar 1.

15.

Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.

Adelfinger M, Gentschev I, Grimm de Guibert J, Weibel S, Langbein-Laugwitz J, Härtl B, Murua Escobar H, Nolte I, Chen NG, Aguilar RJ, Yu YA, Zhang Q, Frentzen A, Szalay AA.

PLoS One. 2014 Aug 5;9(8):e104337. doi: 10.1371/journal.pone.0104337. eCollection 2014.

16.

Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains.

Stritzker J, Huppertz S, Zhang Q, Geissinger U, Härtl B, Gentschev I, Szalay AA.

J Virol. 2014 Oct;88(19):11556-67. doi: 10.1128/JVI.00681-14. Epub 2014 Jul 23.

17.

Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model.

Donat U, Rother J, Schäfer S, Hess M, Härtl B, Kober C, Langbein-Laugwitz J, Stritzker J, Chen NG, Aguilar RJ, Weibel S, Szalay AA.

PLoS One. 2014 Jun 2;9(6):e98533. doi: 10.1371/journal.pone.0098533. eCollection 2014.

18.

A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation.

Ching W, Koyuncu E, Singh S, Arbelo-Roman C, Hartl B, Kremmer E, Speiseder T, Meier C, Dobner T.

PLoS Pathog. 2013 Mar;9(3):e1003273. doi: 10.1371/journal.ppat.1003273. Epub 2013 Mar 28.

19.

Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.

Donat U, Weibel S, Hess M, Stritzker J, Härtl B, Sturm JB, Chen NG, Gentschev I, Szalay AA.

PLoS One. 2012;7(9):e45942. doi: 10.1371/journal.pone.0045942. Epub 2012 Sep 25.

20.

SU-E-J-116: Investigation of Accuracy and Precision of ITV Delineation by PET SUV Threshold.

Hartl B, Serratore D, Chan P, Neicu T, Li S.

Med Phys. 2012 Jun;39(6Part7):3679. doi: 10.1118/1.4734952.

PMID:
28519795
21.

SU-E-J-134: Motion Modeling of Non-Small Cell Lung Nodules Based on Respiratory Mechanics.

Serratore D, Hartl B, Chan P, Neicu T, Li S.

Med Phys. 2012 Jun;39(6Part8):3683. doi: 10.1118/1.4734970.

PMID:
28518891
22.

Fluorescence Lifetime Spectroscopy and Imaging in Neurosurgery.

Marcu L, Hartl BA.

IEEE J Sel Top Quantum Electron. 2012 Jul-Aug;18(4):1465-1477. doi: 10.1109/JSTQE.2012.2185823. Epub 2012 Jan 24.

23.

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies.

Hess M, Stritzker J, Härtl B, Sturm JB, Gentschev I, Szalay AA.

J Transl Med. 2011 Oct 11;9:172. doi: 10.1186/1479-5876-9-172.

24.

Local health department 2009 H1N1 influenza vaccination clinics-CDC staffing model comparison and other best practices.

Porter D, Hall M, Hartl B, Raevsky C, Peacock R, Kraker D, Walls S, Brink G.

J Public Health Manag Pract. 2011 Nov-Dec;17(6):530-3. doi: 10.1097/PHH.0b013e31822146eb.

PMID:
21964365
25.

Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.

Hartl B, Hainisch EK, Shafti-Keramat S, Kirnbauer R, Corteggio A, Borzacchiello G, Tober R, Kainzbauer C, Pratscher B, Brandt S.

J Gen Virol. 2011 Oct;92(Pt 10):2437-2445. doi: 10.1099/vir.0.033670-0. Epub 2011 Jun 29.

26.

Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.

Härtl B, Zeller T, Blanchette P, Kremmer E, Dobner T.

Oncogene. 2008 Jun 12;27(26):3673-84. doi: 10.1038/sj.onc.1211039. Epub 2008 Jan 21.

PMID:
18212738
27.

Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation.

Kindsmüller K, Groitl P, Härtl B, Blanchette P, Hauber J, Dobner T.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6684-9. Epub 2007 Apr 11.

28.

Biomanufacturing: a high-growth industry for North Carolina.

Hartl B.

Drug Discov Today. 2005 Nov 15;10(22):1494-7.

PMID:
16257370
29.
30.

Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma.

Kraker AJ, Mizzen CA, Hartl BG, Miin J, Allis CD, Merriman RL.

Mol Cancer Ther. 2003 Apr;2(4):401-8.

31.

Development of a new integration site within the Bacillus subtilis chromosome and construction of compatible expression cassettes.

Härtl B, Wehrl W, Wiegert T, Homuth G, Schumann W.

J Bacteriol. 2001 Apr;183(8):2696-9. Erratum in: J Bacteriol 2001 Jul;183(14):4393.

32.

3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.

Thompson AM, Connolly CJ, Hamby JM, Boushelle S, Hartl BG, Amar AM, Kraker AJ, Driscoll DL, Steinkampf RW, Patmore SJ, Vincent PW, Roberts BJ, Elliott WL, Klohs W, Leopold WR, Showalter HD, Denny WA.

J Med Chem. 2000 Nov 2;43(22):4200-11.

PMID:
11063616
33.

Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.

Kraker AJ, Hartl BG, Amar AM, Barvian MR, Showalter HD, Moore CW.

Biochem Pharmacol. 2000 Oct 1;60(7):885-98.

PMID:
10974196
34.

Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src).

Thompson AM, Rewcastle GW, Boushelle SL, Hartl BG, Kraker AJ, Lu GH, Batley BL, Panek RL, Showalter HD, Denny WA.

J Med Chem. 2000 Aug 10;43(16):3134-47.

PMID:
10956222
35.

Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor.

Palmer BD, Kraker AJ, Hartl BG, Panopoulos AD, Panek RL, Batley BL, Lu GH, Trumpp-Kallmeyer S, Showalter HD, Denny WA.

J Med Chem. 1999 Jul 1;42(13):2373-82.

PMID:
10395478
36.

Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.

Boschelli DH, Wu Z, Klutchko SR, Showalter HD, Hamby JM, Lu GH, Major TC, Dahring TK, Batley B, Panek RL, Keiser J, Hartl BG, Kraker AJ, Klohs WD, Roberts BJ, Patmore S, Elliott WL, Steinkampf R, Bradford LA, Hallak H, Doherty AM.

J Med Chem. 1998 Oct 22;41(22):4365-77.

PMID:
9784112
37.

2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.

Klutchko SR, Hamby JM, Boschelli DH, Wu Z, Kraker AJ, Amar AM, Hartl BG, Shen C, Klohs WD, Steinkampf RW, Driscoll DL, Nelson JM, Elliott WL, Roberts BJ, Stoner CL, Vincent PW, Dykes DJ, Panek RL, Lu GH, Major TC, Dahring TK, Hallak H, Bradford LA, Showalter HD, Doherty AM.

J Med Chem. 1998 Aug 13;41(17):3276-92.

PMID:
9703473

Supplemental Content

Support Center